SPDR S&P Biotech Company Profile (NYSEARCA:XBI)

About SPDR S&P Biotech

SPDR S&P Biotech logoSPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Exchange Traded Fund
  • Sub-Industry: N/A
  • Exchange: NYSEARCA
  • Symbol: XBI
  • CUSIP:
Key Metrics:
  • Previous Close: $61.04
  • 50 Day Moving Average: $60.99
  • 200 Day Moving Average: $55.43
  • 52-Week Range: $44.16 - $80.64
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $N/A
Additional Links:
Companies Related to SPDR S&P Biotech:

Analyst Ratings

Consensus Ratings for SPDR S&P Biotech (NYSEARCA:XBI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for SPDR S&P Biotech (NYSEARCA:XBI)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends


Dividend History for SPDR S&P Biotech (NYSEARCA:XBI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/19/2015quarterly$0.440.69%6/19/20156/23/20156/29/2015
3/20/2015quarterly$0.250.42%3/20/20153/24/20153/30/2015
12/19/2014quarterly$0.491.03%12/19/201412/23/201412/30/2014
9/19/2014quarterly$0.561.42%9/19/20149/23/20149/29/2014
6/20/2014quarterly$0.621.61%6/20/20146/24/20146/30/2014
3/21/2014quarterly$0.330.87%3/21/20143/25/20143/31/2014
12/20/2013quarterly$0.040.12%12/20/201312/24/201312/31/2013
9/20/2013quarterly$0.090.27%9/20/20139/24/20139/30/2013
3/15/2013quarterly$0.040.18%3/15/20133/19/20133/25/2013
12/21/2012quarterly$0.200.89%12/21/201212/26/20121/4/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for SPDR S&P Biotech (NYSEARCA:XBI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for SPDR S&P Biotech (NYSEARCA:XBI)
DateHeadline
blogs.barrons.com logoBiotech Stocks: Look Who's Selling - Barron's (blog) (NYSEARCA:XBI)
blogs.barrons.com - August 31 at 5:57 AM
marketrealist.com logoGeneric Competition Not a Threat to UTHR's Remodulin - Market ... - Market Realist (NYSEARCA:XBI)
marketrealist.com - August 31 at 5:57 AM
nasdaq.com logoSPDR S&P Biotech ETF Experiences Big Inflow - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 31 at 5:57 AM
blogs.barrons.com logoBiotech Stocks: Look Who's Selling (NYSEARCA:XBI)
blogs.barrons.com - August 29 at 8:16 PM
marketrealist.com logoCould Zinbryta Become a Novel Immunomodulatory Therapy for MS? (NYSEARCA:XBI)
marketrealist.com - August 26 at 11:12 AM
finance.yahoo.com logoBiotech ETFs in Focus After Mylan's EpiPen Controversy (NYSEARCA:XBI)
finance.yahoo.com - August 26 at 11:12 AM
benzinga.com logoBiotechs Are Down 17% Since Clinton First Put Industry On Blast Last September - Benzinga (NYSEARCA:XBI)
www.benzinga.com - August 25 at 8:35 PM
finance.yahoo.com logoClinton Mylan Attack Reminds Biotech ETF Investors of Election Risks (NYSEARCA:XBI)
finance.yahoo.com - August 25 at 8:35 PM
marketrealist.com logoHow Humira-Related Uncertainty Has Affected AbbVie's Valuations - Market Realist (NYSEARCA:XBI)
marketrealist.com - August 24 at 8:06 PM
nasdaq.com logoNotable Two Hundred Day Moving Average Cross - BLUE - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 24 at 8:06 PM
benzinga.com logoBiotechs Are Getting Crushed After Clinton And The White House Trash EpiPen Price Hike - Benzinga (NYSEARCA:XBI)
www.benzinga.com - August 24 at 8:06 PM
benzinga.com logoHow Advisors Evaluate Industry, Sector ETFs - Benzinga (NYSEARCA:XBI)
www.benzinga.com - August 24 at 8:06 PM
marketwatch.com logoMedivation shareholders should be 'thrilled' about price of Pfizer deal: analysts - MarketWatch (NYSEARCA:XBI)
www.marketwatch.com - August 24 at 11:25 AM
marketrealist.com logoMedivation: The Latest Analyst Recommendations (NYSEARCA:XBI)
marketrealist.com - August 24 at 11:25 AM
marketrealist.com logoWhat Are Analysts' Recommendations for AbbVie in 2016? - Market Realist (NYSEARCA:XBI)
marketrealist.com - August 23 at 8:28 PM
finance.yahoo.com logoPfizer Acquires Medivation, Renews Biotech M&A Bets - Yahoo Finance (NYSEARCA:XBI)
finance.yahoo.com - August 23 at 8:28 PM
nasdaq.com logoXBI, IONS, SRPT, BLUE: ETF Outflow Alert - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 23 at 8:28 PM
News IconIt Could Be An Interesting Ride For Healthcare ETFs - Fox Business (NYSEARCA:XBI)
www.foxbusiness.com - August 23 at 8:28 PM
cnn.com logoIt Could Be An Interesting Ride For Healthcare ETFs (NYSEARCA:XBI)
money.cnn.com - August 23 at 10:56 AM
News IconPfizer Acquires Medivation, Renews Biotech M&A Bets (NYSEARCA:XBI)
www.etftrends.com - August 22 at 8:17 PM
mysmartrend.com logoSmarTrend Watching for Potential Pullback in Shares of SPDR S&P Biotech ETF After 1.97% Gain (NYSEARCA:XBI)
www.mysmartrend.com - August 22 at 8:17 PM
marketwatch.com logoMedivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts (NYSEARCA:XBI)
www.marketwatch.com - August 22 at 8:17 PM
News IconThis Is Why Beating the Stock Market Is All Relative (NYSEARCA:XBI)
www.moneyandmarkets.com - August 19 at 11:19 AM
marketrealist.com logoWhich Sectors to Avoid if Inflation Rises - Market Realist (NYSEARCA:XBI)
marketrealist.com - August 17 at 8:40 PM
News IconHealthcare Investors May Be Pricing In A Clinton Victory - Fox Business (NYSEARCA:XBI)
www.foxbusiness.com - August 17 at 8:40 PM
finance.yahoo.com logoHealthcare Investors May Be Pricing In A Clinton Victory (NYSEARCA:XBI)
finance.yahoo.com - August 17 at 11:19 AM
marketrealist.com logoAccording to Janus, These Sectors Are Immune to Rising Inflation - Market Realist (NYSEARCA:XBI)
marketrealist.com - August 16 at 8:26 PM
nasdaq.com logoAnother Endorsement for Biotech ETFs - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 16 at 8:26 PM
marketrealist.com logoUS Consumer Sentiment Is Below the Forecast (NYSEARCA:XBI)
marketrealist.com - August 16 at 11:43 AM
finance.yahoo.com logoTuesday links: operating in silos (NYSEARCA:XBI)
finance.yahoo.com - August 16 at 11:43 AM
News IconBulls are chasing uptrend in biotech fund - optionMONSTER Research (NYSEARCA:XBI)
www.optionmonster.com - August 15 at 8:41 PM
businesswire.com logoState Street Global Advisors Announces Impact of SPDR® S&P® Biotech ETF's Receipt of Settlement Payment - Business Wire (press release) (NYSEARCA:XBI)
www.businesswire.com - August 15 at 8:41 PM
News IconBiotech Sector (IBB): Is The Rally Just Getting Started? - See It Market (blog) (NYSEARCA:XBI)
www.seeitmarket.com - August 15 at 8:41 PM
finance.yahoo.com logoBulls are chasing uptrend in biotech fund (NYSEARCA:XBI)
finance.yahoo.com - August 15 at 8:41 PM
News IconFinance: Hold on to stocks, more rallies are coming - Phuket Gazette (NYSEARCA:XBI)
www.phuketgazette.net - August 15 at 10:22 AM
barrons.com logoHillary Rising - Barron's (NYSEARCA:XBI)
www.barrons.com - August 14 at 5:49 AM
News IconCheap Funds Dupe Investors – 3Q16 - ValueWalk (NYSEARCA:XBI)
www.valuewalk.com - August 14 at 5:49 AM
nasdaq.com logoXBI, IONS, SRPT, BLUE: ETF Inflow Alert - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 12 at 8:29 PM
mysmartrend.com logoSmarTrend Watching for Potential Rebound in Shares of SPDR S&P Biotech ETF After 2.50% Loss (NYSEARCA:XBI)
www.mysmartrend.com - August 12 at 11:40 AM
investopedia.com logoActive Traders Turn Bullish on Biotech (IBB, XBI) (NYSEARCA:XBI)
www.investopedia.com - August 12 at 11:40 AM
investopedia.com logoActive Traders Turn Bullish on Biotech - Investopedia (NYSEARCA:XBI)
www.investopedia.com - August 11 at 8:59 PM
investopedia.com logoActive Traders Turn Bullish on Biotech (NYSEARCA:XBI)
www.investopedia.com - August 11 at 8:59 PM
investorplace.com logoSPDR S&P Biotech (ETF) (XBI): Embrace the Biotech Bulls’ Return (NYSEARCA:XBI)
investorplace.com - August 11 at 11:41 AM
marketwatch.com logoImpax Laboratories stock plunges as competition pushes results well below expectations - MarketWatch (NYSEARCA:XBI)
www.marketwatch.com - August 9 at 11:51 AM
finance.yahoo.com logoCrushed Bio-Tech leader falls 90%, now attempting breakout (NYSEARCA:XBI)
finance.yahoo.com - August 9 at 11:51 AM
finance.yahoo.com logoMore Support for Biotech ETFs as Value Plays - Yahoo Finance (NYSEARCA:XBI)
finance.yahoo.com - August 8 at 8:34 PM
nasdaq.com logoXBI, IONS, SRPT, TSRO: Large Outflows Detected at ETF - Nasdaq (NYSEARCA:XBI)
www.nasdaq.com - August 6 at 8:12 PM
News IconAmid Biotech Rally, Investors Show Jitters - ETF Trends (NYSEARCA:XBI)
www.etftrends.com - August 6 at 8:12 PM
forbes.com logoThursday's ETF Movers: XOP, XBI (NYSEARCA:XBI)
www.forbes.com - August 4 at 8:50 PM
finance.yahoo.com logoAmid Biotech Rally, Investors Show Jitters (NYSEARCA:XBI)
finance.yahoo.com - August 4 at 11:39 AM

Social


Last Updated on 8/31/2016 by MarketBeat.com Staff